Clearwater Analytics' acquisition of Enfusion for $1.5 billion seeks not just to expand its foothold but also to build a comprehensive front-to-back platform for the investment management industry.
The deal, backed by $800 million in loans and a $200 million revolving line of credit, places a significant emphasis on integrating Enfusion’s advanced portfolio management technology into Clearwater's existing services.
Enfusion's recent financial growth, including approximately 15% revenue growth and 13% growth in annual recurring revenue, has strengthened Clearwater's position as they assert that paying a 13% premium is justified.
Clearwater anticipates the completion of the acquisition by Q2 2025, contingent on shareholder and regulatory approvals, marking a strategic step towards enhancing its capabilities in the hedge fund sector.
Collection
[
|
...
]